Multi-university study shows app can help students reduce symptoms, ease depression
Such delays lead to serious disparities in access to developmental therapy
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
Grant from National Institute on Drug Abuse to extend landmark study
Low levels of neuropeptide in babies’ cerebrospinal fluid linked to later diagnosis.
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.
Research from Washington University in St. Louis is narrowing the gap in psychology’s understanding of suicidal thoughts in young people. The findings show that such thoughts begin as early as 9 and 10 years old.
Research focuses on precisely how the disease develops in the brain
Compelled by the potential to improve the lives of vulnerable children, emeritus trustee Walter Metcalfe and his wife, Cynthia, have committed nearly $4 million through outright and estate gifts to support the work of Joan L. Luby, MD, a highly regarded child psychiatrist.